I have "currently incurable" Stage IV colon cancer. I am also Ph.D. scientist in oncology drug discovery. Two of my current life missions: spread the word on the amazing advances seen in immunotherapies and eventually be cured by one!
Dr. Tom Marsilje is a dad, husband, and music lover living with stage 4 colorectal cancer. He’s also a scientist who’s spent the last 20 years in cancer research. Tom writes a monthly column for Fight Colorectal Cancer called “The Currently Incurable Scientist.” He is being treated with a combination of chemotherapies known as FOLFIRI, and the monoclonal antibody Avastin® (bevacizumab).
Sadly, Tom Marsilje passed away in November 2017.
Provide guidance and encouragement to others going through their journey with cancer immunotherapy treatment.
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, 4th Floor | New York, NY 10006-3111
(800) 992-2623(212) 832-9376Staff Directory
Day 4 at AACR18 was a special day for CRI’s Dr. Antoni Ribas, and highlighted his and others’ efforts to overcome resistance to PD-1 therapy as well as insights into the role of dendritic cells.
Day 3 of AACR18 highlighted potentially “practice-changing” immunotherapy breakthroughs in lung cancer, and insights into the factors governing immunotherapy’s effectiveness in several other cancer types